Francesca has decades of experience in domestic and cross-border M&A and private equity transactions across various sectors, including manufacturing, postal services, finance, energy, infrastructure, and life sciences.
Francesca joined the firm in September 2026.
Previously, she worked in the corporate/M&A departments of leading Italian and international law firms, both in Italy and in the United States.
The firm consolidates the practice in extraordinary transactions and in advising Italian and U.S. investors
Majority stake sold in the Italian pharmaceutical company active in neurology, psychiatry, urology and diabetology
What changes from 27 September 2026 and how to prepare
The deal allows Impresoft to focus on proprietary software, digital transformation and AI, while highlighting 4ward’s industrial f ...
The transaction completes the acquisition process launched in 2024